Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one
A group of academics claim the president of EcoHealth Alliance has misled the public amid Covid origins investigations.
Should work done on coronaviruses in Wuhan, China, be considered “gain-of-function” research? Opinions differ.
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.